Reports - Artificial Intelligence In Diagnostics Market
HealthcareArtificial Intelligence In Diagnostics Market
Artificial Intelligence In Diagnostics Market Size, Growth Projections And Insights 2025-2035 by Component (Software, Hardware, Services) by Therapeutic Area (Oncology, Neurodegenerative Disease, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Other Areas) by Application (Drug Optimization & Repurposing, Preclinical Testing, Other Applications) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Artificial Intelligence In Diagnostics Market - Segment Analysis
1. Overview
2. Global Artificial Intelligence In Diagnostics Market, 2021 - 2035 (USD Million)
3. Global Artificial Intelligence In Diagnostics Market - by Component
3.1. By Software
3.2. By Hardware
3.3. By Services
4. Global Artificial Intelligence In Diagnostics Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Disease
4.3. By Cardiovascular Disease
4.4. By Metabolic Disease
4.5. By Infectious Disease
4.6. By Other Areas
5. Global Artificial Intelligence In Diagnostics Market - by Application
5.1. By Drug Optimization & Repurposing
5.2. By Preclinical Testing
5.3. By Other Applications
6. Global Artificial Intelligence In Diagnostics Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Artificial Intelligence In Diagnostics Market - Segment Analysis
1. Overview
2. North America Artificial Intelligence In Diagnostics Market, 2021 - 2035 (USD Million)
3. North America Artificial Intelligence In Diagnostics Market - by Component
3.1. By Software
3.2. By Hardware
3.3. By Services
4. North America Artificial Intelligence In Diagnostics Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Disease
4.3. By Cardiovascular Disease
4.4. By Metabolic Disease
4.5. By Infectious Disease
4.6. By Other Areas
5. North America Artificial Intelligence In Diagnostics Market - by Application
5.1. By Drug Optimization & Repurposing
5.2. By Preclinical Testing
5.3. By Other Applications
Chapter 5 Europe Artificial Intelligence In Diagnostics Market - Segment Analysis
1. Overview
2. Europe Artificial Intelligence In Diagnostics Market, 2021 - 2035 (USD Million)
3. Europe Artificial Intelligence In Diagnostics Market - by Component
3.1. By Software
3.2. By Hardware
3.3. By Services
4. Europe Artificial Intelligence In Diagnostics Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Disease
4.3. By Cardiovascular Disease
4.4. By Metabolic Disease
4.5. By Infectious Disease
4.6. By Other Areas
5. Europe Artificial Intelligence In Diagnostics Market - by Application
5.1. By Drug Optimization & Repurposing
5.2. By Preclinical Testing
5.3. By Other Applications
Chapter 6 Asia Pacific Artificial Intelligence In Diagnostics Market - Segment Analysis
1. Overview
2. Asia Pacific Artificial Intelligence In Diagnostics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Artificial Intelligence In Diagnostics Market - by Component
3.1. By Software
3.2. By Hardware
3.3. By Services
4. Asia Pacific Artificial Intelligence In Diagnostics Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Disease
4.3. By Cardiovascular Disease
4.4. By Metabolic Disease
4.5. By Infectious Disease
4.6. By Other Areas
5. Asia Pacific Artificial Intelligence In Diagnostics Market - by Application
5.1. By Drug Optimization & Repurposing
5.2. By Preclinical Testing
5.3. By Other Applications
Chapter 7 Latin America Artificial Intelligence In Diagnostics Market - Segment Analysis
1. Overview
2. Latin America Artificial Intelligence In Diagnostics Market, 2021 - 2035 (USD Million)
3. Latin America Artificial Intelligence In Diagnostics Market - by Component
3.1. By Software
3.2. By Hardware
3.3. By Services
4. Latin America Artificial Intelligence In Diagnostics Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Disease
4.3. By Cardiovascular Disease
4.4. By Metabolic Disease
4.5. By Infectious Disease
4.6. By Other Areas
5. Latin America Artificial Intelligence In Diagnostics Market - by Application
5.1. By Drug Optimization & Repurposing
5.2. By Preclinical Testing
5.3. By Other Applications
Chapter 8 Middle East & Africa Artificial Intelligence In Diagnostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Artificial Intelligence In Diagnostics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Artificial Intelligence In Diagnostics Market - by Component
3.1. By Software
3.2. By Hardware
3.3. By Services
4. Middle East & Africa Artificial Intelligence In Diagnostics Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Disease
4.3. By Cardiovascular Disease
4.4. By Metabolic Disease
4.5. By Infectious Disease
4.6. By Other Areas
5. Middle East & Africa Artificial Intelligence In Diagnostics Market - by Application
5.1. By Drug Optimization & Repurposing
5.2. By Preclinical Testing
5.3. By Other Applications
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Aidoc (U.S.)
2. AliveCor Inc. (U.S.)
3. Vuni Inc. (U.S.)
4. Digital Diagnostics Inc. (U.S.)
5. Siemens Healthineers (Germany)
6. Neural Analytics (U.S.)
7. Riverain Technologies (U.S.)
8. Zebra Medical Vision Inc. (Israel)
9. GE Healthcare (U.S.)
10. Imagen Technologies (U.S.)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By